Arcellx (ACLX) Current Assets (2021 - 2025)
Arcellx (ACLX) recorded quarterly Current Assets of $462.2 million in Q4 2025, down 2.1% quarter-over-quarter from $472.1 million in Q3 2025, and down 22.88% on a YoY basis from $599.3 million in Q4 2024.
Arcellx (ACLX) Current Assets (2021 - 2025) Analysis & Trends
Arcellx's Current Assets history runs 5 years deep, the most recent figure standing at $462.2 million for Q4 2025.
- In Q4 2025, Current Assets fell 22.88% year-over-year to $462.2 million; the TTM figure through Dec 2025 stood at $462.2 million (down 22.88% YoY), while the FY2025 annual figure was $462.2 million, down 22.88% from the prior year.
- Current Assets was $462.2 million for Q4 2025 at Arcellx, down from $472.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $716.4 million in Q4 2023 to a low of $112.8 million in Q4 2021.
- Historically, Current Assets has averaged $459.7 million across 5 years, with a median of $491.5 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Current Assets surged 168.44% in 2023, then decreased 22.88% in 2025.
- A 5-year view of Current Assets shows it stood at $112.8 million in 2021, then surged by 136.56% to $266.9 million in 2022, then soared by 168.44% to $716.4 million in 2023, then fell by 16.34% to $599.3 million in 2024, then fell by 22.88% to $462.2 million in 2025.
- The last three Current Assets figures came in at $462.2 million (Q4 2025), $472.1 million (Q3 2025), and $463.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 462.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 462.18 Mn |
| Sep 30, 2025 | 472.08 Mn |
| Jun 30, 2025 | 463.90 Mn |
| Mar 31, 2025 | 554.15 Mn |
| Dec 31, 2024 | 599.31 Mn |
| Sep 30, 2024 | 587.30 Mn |
| Jun 30, 2024 | 530.20 Mn |
| Mar 31, 2024 | 588.73 Mn |
| Dec 31, 2023 | 716.36 Mn |
| Sep 30, 2023 | 491.46 Mn |
| Jun 30, 2023 | 558.07 Mn |
| Mar 31, 2023 | 571.37 Mn |
| Dec 31, 2022 | 266.86 Mn |
| Sep 30, 2022 | 290.31 Mn |
| Jun 30, 2022 | 325.08 Mn |
| Mar 31, 2022 | 224.39 Mn |
| Dec 31, 2021 | 112.81 Mn |